Nuclear grading versus gleason grading in small samples containing prostate cancer: A tissue microarray study

Pathology and Oncology Research

Volumn 16, Issue 4, 2010, Pages 479-484

  Wittschieber, Daniel ^a   Köllermann, Jens ^b   Schlomm, Thorsten ^b   Sauter, Guido ^b   Erbersdobler, Andreas ^a,c  

^a CHARITÉ UNIVERSITÄTSMEDIZIN BERLIN   (Germany)

^b UNIVERSITY MEDICAL CENTER HAMBURG EPPENDORF   (Germany)

^c UNIVERSITY OF ROSTOCK   (Germany)

Author keywords

Fuhrman nuclear grading; Gleason grading; Prognosis; Prostate cancer; TMA

Indexed keywords

PROSTATE SPECIFIC ANTIGEN;

ADULT; AGED; ARTICLE; CANCER GRADING; CANCER RECURRENCE; CANCER STAGING; CONTROLLED STUDY; FUHRMAN GRADING; GLEASON SCORE; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; INTERMETHOD COMPARISON; MAJOR CLINICAL STUDY; MALE; OUTCOME ASSESSMENT; PROGNOSIS; PROSTATE CANCER; PROSTATECTOMY; SCORING SYSTEM; TISSUE MICROARRAY; TISSUE SECTION;

AGED; CELL NUCLEUS; HISTOCYTOCHEMISTRY; HUMANS; KAPLAN-MEIER ESTIMATE; MALE; MIDDLE AGED; NEOPLASM STAGING; PROSTATE-SPECIFIC ANTIGEN; PROSTATECTOMY; PROSTATIC NEOPLASMS; TISSUE ARRAY ANALYSIS;

EID: 78149407124     PISSN: 12194956     EISSN: None     Source Type: Journal    
DOI: 10.1007/s12253-010-9270-x     Document Type: Article

References (29)

1. DF Gleason 1966 Classification of prostatic carcinomas Cancer Chemother Rep 50 125 128 1:STN:280:DyaF287ht1WgsA%3D%3D 5948714
2. DF Gleason GT Mellinger 1974 Prediction of prognosis for prostatic adenocarcinoma by combined histological grading and clinical staging J Urol 111 58 64 1:STN:280:DyaE2c7gt1Clug%3D%3D 4813554
3. DF Gleason 1992 Histologic grading of prostate cancer: a perspective Hum Pathol 23 273 279 1:STN:280:DyaK383htVWjug%3D%3D 10.1016/0046-8177(92)90108-F 1555838
4. JI Epstein G Pizov PC Walsh 1993 Correlation of pathologic findings with progression after radical retropubic prostatectomy Cancer 71 3582 3593 1:STN:280:DyaK3s3lvVOgtQ%3D%3D 10.1002/1097-0142(19930601)71:11<3582::AID- CNCR2820711120>3.0.CO;2-Y 7683970 (Pubitemid 23152669)
5. JE Oesterling CB Brendler JI Epstein, et al. 1987 Correlation of clinical stage, serum prostatic acid phosphatase and preoperative Gleason grade with final pathological stage in 275 patients with clinically localized adenocarcinoma of the prostate J Urol 138 92 98 1:STN:280:DyaL2s3lsVGitA%3D%3D 3599229
6. F Di Silverio G D'Eramo M Buscarini, et al. 1996 DNA ploidy, Gleason score, pathological stage and serum PSA levels as predictors of disease-free survival in C-D1 prostatic cancer patients submitted to radical retropubic prostatectomy Eur Urol 30 316 321 8931963
7. PC Sogani A Israel PH Lieberman, et al. 1985 Gleason grading of prostate cancer: a predictor of survival Urology 25 223 227 1:STN:280: DyaL2M7ktlKqsg%3D%3D 10.1016/0090-4295(85)90316-4 3976112 (Pubitemid 16036058)
8. DG Bostwick CS Foster 1999 Predictive factors in prostate cancer: current concepts from the 1999 College of American Pathologists Conference on Solid Tumor Prognostic Factors and the 1999 World Health Organization Second International Consultation on Prostate Cancer Semin Urol Oncol 17 222 272 1:STN:280:DC%2BD3c%2FpsF2rtg%3D%3D 10632123
9. PA Humphrey 2004 Gleason grading and prognostic factors in carcinoma of the prostate Mod Pathol 17 292 306 10.1038/modpathol.3800054 14976540 (Pubitemid 41646608)
10. JI Epstein M Carmichael AW Partin, et al. 1993 Is tumor volume an independent predictor of progression following radical prostatectomy? A multivariate analysis of 185 clinical stage B adenocarcinomas of the prostate with 5 years of followup J Urol 149 1478 1481 1:STN:280:DyaK3s3nsVOgtw%3D%3D 8501792
11. JI Epstein MJ Carmichael G Pizov, et al. 1993 Influence of capsular penetration on progression following radical prostatectomy: a study of 196 cases with long-term followup J Urol 150 135 141 1:STN:280:DyaK3s3oslarsA%3D%3D 7685422
12. AJ Egan DG Bostwick 1997 Prediction of extraprostatic extension of prostate cancer based on needle biopsy findings: perineural invasion lacks significance on multivariate analysis Am J Surg Pathol 21 1496 1500 1:STN:280:DyaK1c%2FnsFSjtw%3D%3D 10.1097/00000478-199712000-00013 9414194 (Pubitemid 27528261)
13. AI Sagalowsky H Milam LR Reveley 1982 Prediction of lymphatic metastases by Gleason histologic grading in prostatic cancer J Urol 128 951 952 1:STN:280:DyaL3s%2Fos1SnsQ%3D%3D 7176058
14. JF Gaeta JE Asirwatham G Miller, et al. 1980 Histologic grading of primary prostatic cancer: a new approach to an old problem J Urol 123 689 693 1:STN:280:DyaL3M%2FivVegtw%3D%3D 6999173
15. A Böcking J Kiehn M Heinzel-Wach 1982 Combined histologic grading of prostatic carcinoma Cancer 50 288 294 10.1002/1097-0142(19820715)50:2<288:: AID-CNCR2820500220>3.0.CO;2-S 7083133 (Pubitemid 12089388)
16. M Zhou S Hayasaka JM Taylor, et al. 2001 Lack of association of prostate carcinoma nuclear grading with prostate specific antigen recurrence after radical prostatectomy J Urol 166 2193 2197 1:STN:280:DC%2BD3MnksVeisw%3D%3D 10.1016/S0022-5347(05)65533-4 11696734
17. MA Khan PC Walsh MC Miller, et al. 2003 Quantitative alterations in nuclear structure predict prostate carcinoma distant metastasis and death in men with biochemical recurrence after radical prostatectomy Cancer 98 2583 2591 10.1002/cncr.11852 14669277 (Pubitemid 37509521)
18. RW Veltri MC Miller S Isharwal, et al. 2008 Prediction of prostate-specific antigen recurrence in men with long-term follow-up postprostatectomy using quantitative nuclear morphometry Cancer Epidemiol Biomark Prev 17 102 110 1:CAS:528:DC%2BD1cXmt12isw%3D%3D 10.1158/1055-9965.EPI- 07-0175 (Pubitemid 351196279)
19. SA Fuhrman LC Lasky C Limas 1982 Prognostic significance of morphologic parameters in renal cell carcinoma Am J Surg Pathol 6 655 663 1:STN:280:DyaL3s%2FpvVWhtg%3D%3D 10.1097/00000478-198210000-00007 7180965
20. L Bubendorf J Kononen P Koivisto, et al. 1999 Survey of gene amplifications during prostate cancer progression by high-throughout fluorescence in situ hybridization on tissue microarrays Cancer Res 59 803 806 1:CAS:528:DyaK1MXht1Sjurc%3D 10029066
21. T Schlomm P Kirstein L Iwers, et al. 2007 Clinical significance of epidermal growth factor receptor protein overexpression and gene copy number gains in prostate cancer Clin Cancer Res 13 6579 6584 1:CAS:528: DC%2BD2sXhtlSmu7jE 10.1158/1078-0432.CCR-07-1257 18006757 (Pubitemid 350206791)
22. T Schlomm L Iwers P Kirstein, et al. 2008 Clinical significance of p53 alterations in surgically treated prostate cancers Mod Pathol 21 1371 1378 1:CAS:528:DC%2BD1cXhsVemt7%2FO 10.1038/modpathol.2008.104 18552821
23. A Erbersdobler H Isbarn I Steiner, et al. 2009 Predictive value of prostate-specific antigen expression in prostate cancer: a tissue microarray study Urology 74 1169 1173 10.1016/j.urology.2009.02.061 19476978
24. AM DeMarzo WG Nelson WB Isaacs, et al. 2003 Pathological and molecular aspects of prostate cancer Lancet 361 955 964 1:CAS:528:DC%2BD3sXitVKmtLY%3D 10.1016/S0140-6736(03)12779-1 12648986 (Pubitemid 36332115)
25. JI Epstein 2004 Diagnosis and reporting of limited adenocarcinoma of the prostate on needle biopsy Mod Pathol 17 307 315 10.1038/modpathol.3800050 14739905 (Pubitemid 41646609)
26. DA Diamond SJ Berry C Umbricht, et al. 1982 Computerized image analysis of nuclear shape as a prognostic factor for prostatic cancer Prostate 3 321 332 1:STN:280:DyaL3s%2FhsVKgsQ%3D%3D 10.1002/pros.2990030402 7122329 (Pubitemid 12062284)
27. AW Partin AC Walsh RV Pitcock, et al. 1982 A comparison of nuclear morphometry and Gleason grade as a predictor of prognosis in stage A2 prostate cancer: a critical analysis J Urol 142 1254 1258
28. F Robutti FP Pilato PG Betta 1989 A new method of grading malignancy of prostate carcinoma using quantitative microscopic nuclear features Pathol Res Pract 185 701 703 1:STN:280:DyaK3c7nsFWmtQ%3D%3D 2626378
29. K Fujikawa M Sasaki Y Arai, et al. 1997 Prognostic criteria in patients with prostate cancer: Gleason score versus volume-weighted mean nuclear volume Clin Cancer Res 3 613 618 1:STN:280:DyaK1M%2FjsFehug%3D%3D 9815728